| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19:02 | FluoGuide A/S: FluoGuide Enters Collaboration with Leica Microsystems, a World Leading Medical Technology Company | 255 | ACCESS Newswire | KØBENHAVN, DK / ACCESS Newswire / October 2, 2026 / FluoGuide A/S (STO:FLUO) FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery, announces a collaboration... ► Artikel lesen | |
| 18:58 | Carlsmed names chief product and AI officer as it claims CMS reimbursements | - | MassDevice | ||
| 18:24 | Eurofins Scientific SE: Director/PDMR Shareholding | 224 | Business Wire | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| 18:18 | Perimeter Medical Imaging AI Inc: Perimeter Medical appoints Caron as director | 1 | Stockwatch | ||
| 18:15 | Dividendenbekanntmachungen (02.10.2026) | 2.447 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACME UNITED CORPORATION US0048161048 0,16 USD 0,1423 EUR ALICO INC US0162301040 0,05 USD 0,0444 EUR ATN INTERNATIONAL INC US00215F1075 0... ► Artikel lesen | |
| 17:48 | Perspective Therapeutics, Inc.: Perspective Therapeutics Announces Acceptance of [212Pb]VMT01 Data for Presentation at SITC 2026 | 2 | GlobeNewswire (USA) | ||
| 17:30 | Cardinal Health mit ALARM: Diese brandneue Prognose ändert einfach alles - Jetzt handeln, noch vor dem Wochenende! | Hebelschein-Spekulant | |||
| 17:18 | XFRA ISIN CHANGE | 261 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA86332K4000 Strikepoint Gold Inc. 02.10.2026 CA86332K5098 Strikepoint Gold Inc. 05.10.2026 Tausch 10:1 CA6960732049 Palamina... ► Artikel lesen | |
| 17:06 | Renalytix PLC - Director/PDMR Shareholding (Replacement) | 2 | RNS | ||
| 16:56 | Renalytix PLC - Holding(s) in Company | - | RNS | ||
| 16:54 | Chemometec A/S: Completion of share buyback programme | 1 | GlobeNewswire (USA) | ||
| 16:41 | JXR (01951): UPDATE ON IMPLEMENTATION OF THE SHAREHOLDER RETURN PLAN | 1 | HKEx | ||
| 16:34 | DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care | 5 | Zacks | ||
| 16:15 | DAX wenig bewegt - BASF, Evonik, Gerresheimer, VW: Was Anleger wissen müssen Video | 589 | 4investors | Markus Königer, Market Making Derivatives Products der ICF BANK AG, fasst die vergangene Handelswoche zusammen. Der DAX präsentiert sich wenig bewegt, was angesichts der hohen Inflation und dem volatile... ► Artikel lesen | |
| 15:59 | Stocks in Play: WELL Health Technologies Corp. | 1 | Baystreet.ca | ||
| 15:48 | SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026 | 1 | GlobeNewswire (USA) | ||
| 15:42 | Eurofins Acquires Element's North American Testing Business for $400M | 3 | Contract Pharma | ||
| 15:42 | BMO Capital reiterates Outperform on BrightSpring Health stock | 2 | Investing.com | ||
| 15:34 | Can ISRG Offset China Weakness With Expansion in India and Japan? | 5 | Zacks | ||
| 15:18 | Stifel reiterates Hold on ResMed stock amid market share concerns | 2 | Investing.com |
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | Aktuelle Nachrichten | |||
|---|---|---|---|---|---|---|---|
| RESMED | 10 | 19 | +0,51 % | Stifel reiterates Hold on ResMed stock amid market share concerns | |||
| EUROFINS SCIENTIFIC | 7 | 3 | +0,89 % | Eurofins Scientific SE: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | ||
| FRESENIUS | 6 | 14 | -0,38 % | Fresenius baut Kapazität in Europa für 54 Mio Euro aus | DJ Fresenius baut Kapazität in Europa für 54 Mio Euro aus
DOW JONES--Fresenius hat seine Kapazitäten für die Herstellung von Infusionslösungen in Polen und Italien erweitert. Wie der DAX-Konzern... ► Artikel lesen | ||
| SCIENTURE | 5 | - | -16,58 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA86332K4000 Strikepoint Gold Inc. 02.10.2026 CA86332K5098 Strikepoint Gold Inc. 05.10.2026 Tausch 10:1 CA6960732049 Palamina... ► Artikel lesen | ||
| ULTRAGREEN.AI | 5 | - | 0,00 % | ULTRAGREEN.AI LIMITED: GENERAL ANNOUNCEMENT::ULTRAGREEN.AI ANNOUNCES BOARD CHANGES TO SUPPORT ITS NEXT PHASE OF DEVELOPMENT | |||
| ENSIGN GROUP | 4 | 11 | -0,99 % | Dividendenbekanntmachungen (30.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIA REALTY TRUST US0042391096 0,2 USD 0,1763 EUR ADVANCED FLOWER CAPITAL INC US00109K1051 0,05 USD 0,044 EUR AGNC INVESTMENT... ► Artikel lesen | ||
| GERRESHEIMER | 4 | 7 | -0,72 % | EQS-AFR: Gerresheimer AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Gerresheimer AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Gerresheimer AG: Vorabbekanntmachung über... ► Artikel lesen | ||
| MANGOCEUTICALS | 4 | 2 | -9,01 % | Mangoceuticals, Inc.: Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche | Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company's Antiviral Intellectual Property Portfolio with No Issuance of MGRX Common Stock DALLAS, TEXAS, Oct. 01, 2026... ► Artikel lesen | ||
| AXOGEN | 4 | - | -8,10 % | Axogen, Inc.: Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair | ALACHUA, Fla. and TAMPA, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. ("Axogen" or the "Company") (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions... ► Artikel lesen | ||
| BOSTON SCIENTIFIC | 3 | 7 | -0,51 % | Elutia Inc.: Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029 | Boston Scientific released the full $8 million holdback on schedule and with no claimsEscrow release is the third funding catalyst Elutia has delivered in 2026, following the August closings of its... ► Artikel lesen |
| Unternehmen / Aktien | Aktueller Kurs | Ø Kursziel (Euro) | Potential (Euro) | kaufen | halten | verkaufen | |||
|---|---|---|---|---|---|---|---|---|---|
| ECKERT & ZIEGLER SE | 12,350 | 23 | +86 % | 1 | - | - | |||
| OTTOBOCK SE & CO KGAA | 50,80 | 80 | +57 % | 9 | 2 | - | |||
| ESSILORLUXOTTICA SA | 142,95 | 218,43 | +53 % | 14 | 10 | - | |||
| STRATEC SE | 21,700 | 29 | +34 % | 1 | 2 | - | |||
| FRESENIUS SE & CO KGAA | 43,635 | 56,12 | +29 % | 17 | - | - | |||
| SIEMENS HEALTHINEERS AG | 37,860 | 44,84 | +18 % | 14 | 9 | - | |||
| FRESENIUS MEDICAL CARE AG | 39,550 | 39,45 | 0 % | 1 | 8 | 8 | |||
| GERRESHEIMER AG | 27,520 | 25,67 | -7 % | 3 | 11 | 3 | |||
| CARL ZEISS MEDITEC AG | 31,300 | 26,96 | -14 % | - | 13 | 4 |